Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 2020, 12, 1317

By sjmartinez • January 11, 2024

Dutta P, Paico K, Gomez G, Wu Y, Vadgama JV. Correction: Dutta et al. Transcriptional Regulation of CCL2 by PARP1 Is a Driver for Invasiveness in Breast Cancer. Cancers 2020, 12, 1317. Cancers (Basel). 2023 Dec 19;16(1):7. doi: 10.3390/cancers16010007. Erratum for: Cancers (Basel). 2020 May 21;12(5): PMID: 38201664.

Tags: General Internal Medicine, King Drew Med Ctr, Publications

Evolving growth hormone deficiency: proof of concept

Chimatapu SN, Sethuram S, Samuels JG, Klomhaus A, Mintz C, Savage MO, Rapaport R. Evolving growth hormone deficiency: proof of concept. Front Endocrinol (Lausanne). 2024[...]

Investigating MRI-Associated Biological Aspects of Racial Disparities in Prostate Cancer for African American and White Men

Zabihollahy F, Miao Q, Naim S, Sonni I, Vangala S, Kim H, Hsu W, Sisk A, Reiter R, Raman SS, Sung K. Investigating MRI-Associated Biological[...]

A structured approach to modifying an implementation package while scaling up a complex evidence-based practice

Cordasco KM, Gabrielian SE, Barnard J, Harris T, Finley EP. A structured approach to modifying an implementation package while scaling up a complex evidence-based practice.[...]